Fibrobiologics (NASDAQ: FBLG) reported Q4 2023 earnings per share (EPS) of -$0.35, up 600% year over year. Total Fibrobiologics earnings for the quarter were -$9.72 million. In the same quarter last year, Fibrobiologics's earnings per share (EPS) was -$0.05.
As of Q2 2024, Fibrobiologics's earnings has grown year over year. Fibrobiologics's earnings in the past year totalled -$19.06 million.
What was FBLG's revenue last quarter?
Fibrobiologics (NASDAQ: FBLG) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Fibrobiologics's revenue was $0.00.
What was FBLG's revenue growth in the past year?
As of Q2 2024, Fibrobiologics's revenue has grown null year over year. Fibrobiologics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.